Bank of America’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-31,257
| Closed | -$144K | – | 7614 |
|
|
2019
Q1 | $144K | Sell |
31,257
-872
| -3% | -$4.13K | ﹤0.01% | 5685 |
|
|
2018
Q4 | $112K | Buy |
32,129
+6,462
| +25% | +$44.9K | ﹤0.01% | 5851 |
|
|
2018
Q3 | $259K | Buy |
25,667
+17,252
| +205% | +$138K | ﹤0.01% | 5343 |
|
|
2018
Q2 | $61K | Sell |
8,415
-173
| -2% | -$1.21K | ﹤0.01% | 6038 |
|
|
2018
Q1 | $52K | Sell |
8,588
-10,722
| -56% | -$88.5K | ﹤0.01% | 6035 |
|
|
2017
Q4 | $186K | Sell |
19,310
-15,005
| -44% | -$98.2K | ﹤0.01% | 5444 |
|
|
2017
Q3 | $305K | Buy |
34,315
+7,249
| +27% | +$74.8K | ﹤0.01% | 5199 |
|
|
2017
Q2 | $342K | Sell |
27,066
-14,408
| -35% | -$171K | ﹤0.01% | 5081 |
|
|
2017
Q1 | $435K | Sell |
41,474
-85,162
| -67% | -$907K | ﹤0.01% | 4960 |
|
|
2016
Q4 | $1.17M | Buy |
126,636
+114,236
| +921% | +$1.29M | ﹤0.01% | 4219 |
|
|
2016
Q3 | $146K | Sell |
12,400
-725
| -6% | -$11K | ﹤0.01% | 5274 |
|
|
2016
Q2 | $170K | Sell |
13,125
-26,362
| -67% | -$384K | ﹤0.01% | 5288 |
|
|
2016
Q1 | $631K | Buy |
39,487
+378
| +1% | +$7.18K | ﹤0.01% | 4457 |
|
|
2015
Q4 | $1.12M | Sell |
39,109
-15,365
| -28% | -$426K | ﹤0.01% | 4286 |
|
|
2015
Q3 | $1.55M | Buy |
54,474
+29,475
| +118% | +$1.08M | ﹤0.01% | 3981 |
|
|
2015
Q2 | $898K | Buy |
24,999
+15,477
| +163% | +$482K | ﹤0.01% | 4198 |
|
|
2015
Q1 | $277K | Sell |
9,522
-230
| -2% | -$6.08K | ﹤0.01% | 4715 |
|
|
2014
Q4 | $205K | Buy |
9,752
+856
| +10% | +$16.9K | ﹤0.01% | 5352 |
|
|
2014
Q3 | $173K | Sell |
8,896
-17,610
| -66% | -$277K | ﹤0.01% | 5516 |
|
|
2014
Q2 | $414K | Buy |
26,506
+17,020
| +179% | +$275K | ﹤0.01% | 4805 |
|
|
2014
Q1 | $196K | Sell |
9,486
-372,276
| -98% | -$7.38M | ﹤0.01% | 5454 |
|
|
2013
Q4 | $4.93M | Buy |
381,762
+368,016
| +2,677% | +$5.1M | ﹤0.01% | 2487 |
|
|
2013
Q3 | $160K | Sell |
13,746
-6,801
| -33% | -$55.8K | ﹤0.01% | 5638 |
|
|
2013
Q2 | $95K | Buy |
+20,547
| New | +$75.3K | ﹤0.01% | 6198 |
|
Other funds holding INSY
WS
Bank of America's INSY Position: Q2 2019 in Review
Bank of America sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 31,257 shares — an estimated $144K sold.
Bank of America first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $4.93M in Q4 2013. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Bank of America reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of America sold 31,257 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $144K.
- Bank of America first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Bank of America's Insys Therapeutics, Inc. position peaked at $4.93M in Q4 2013.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.